<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>TCA cycle metabolites (urinary) increases colorectal cancer stage progression — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>TCA cycle metabolites (urinary)</strong>
  <span class="pred">&mdash;increases&rarr;</span>
  <strong>colorectal cancer stage progression</strong>
</div>
<div class="entity-id">UNKNOWN:tca cycle metabolites (urinary) &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: DB Referenced (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 4.22<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (DB Referenced, 1 paper)<br>Score from 25 citations: <strong>4.22</strong><br><span style="color:#888">15&times; extends (+1.94) &middot; 8&times; supports (+2.53) &middot; 2&times; contradicts (-0.26)</span><br>Neighbourhood: 6.12</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="DB Referenced"></span><span>DB Referenced</span><a href="https://doi.org/10.1038/s41598-020-78038-2">10.1038/s41598-020-78038-2</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 25 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:53px"></span><span>8</span><span class="cite-subtotal">&middot; +2.53</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">adipose tissue metabolome — predicts → tumour invasiveness in rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/48acf1f78ee7116e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">glutamine — is_biomarker_for → rectal cancer disease stage</span><span class="cite-claim-weight">+0.01</span><a href="../claim/ee7b54ab62786c61.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">fumarate — is_biomarker_for → rectal cancer disease stage</span><span class="cite-claim-weight">+0.01</span><a href="../claim/82051bf9a0591e3c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">rs10411210 (RHPN2 locus SNP) — correlates_with → sucrose</span><span class="cite-claim-weight">+0.50</span><a href="../claim/e6c6d0fdb0cebec2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SLC6A18 SNP — correlates_with → leucine</span><span class="cite-claim-weight">+0.50</span><a href="../claim/c974fa85101a148a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">MAP2K5 SNP — correlates_with → gut microbial metabolites</span><span class="cite-claim-weight">+0.50</span><a href="../claim/8855dd7d8927af48.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">BMP2 SNP — correlates_with → gut microbial metabolites</span><span class="cite-claim-weight">+0.50</span><a href="../claim/422e270f199a7e71.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">RHPN2 intronic region knockout — decreases → downregulated genes (cell division and metabolic processes)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/03252da07b2d27fb.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:13px"></span><span>2</span><span class="cite-subtotal">&middot; -0.26</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">adipose tissue glutamine — decreases → advanced stage rectal cancer</span><span class="cite-claim-weight">-0.01</span><a href="../claim/7896c61b911bbef2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SLC6A18 SNP — correlates_with → tyrosine</span><span class="cite-claim-weight">-0.25</span><a href="../claim/bc94ba872d135be6.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>15</span><span class="cite-subtotal">&middot; +1.94</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">adipose tissue metabolome — distinguishes → rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/6a58dca60a00dc48.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">glutamate — is_biomarker_for → rectal cancer disease stage</span><span class="cite-claim-weight">+0.01</span><a href="../claim/02bb8f293c05b1db.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">succinate — is_biomarker_for → rectal cancer disease stage</span><span class="cite-claim-weight">+0.01</span><a href="../claim/9c5697eb2b7ee5d6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">citrate — is_biomarker_for → rectal cancer tumour invasiveness</span><span class="cite-claim-weight">+0.01</span><a href="../claim/df70eeed4675ee99.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">isocitrate — is_biomarker_for → rectal cancer tumour invasiveness</span><span class="cite-claim-weight">+0.01</span><a href="../claim/e1985235e15c5264.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">TCA cycle metabolites — distinguishes → rectal cancer disease stage</span><span class="cite-claim-weight">+0.01</span><a href="../claim/507fb6f59217330c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">adipose tissue TCA cycle metabolites — predicts → tumour invasiveness in rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/33d5edd83182d292.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">lysophosphatidylcholines — correlates_with → rectal cancer disease stage</span><span class="cite-claim-weight">+0.01</span><a href="../claim/7eb409c76d4a194c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">sphingomyelins — correlates_with → rectal cancer disease stage</span><span class="cite-claim-weight">+0.01</span><a href="../claim/4cd692537b16a5ee.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">phosphatidylcholines — correlates_with → rectal cancer tumour invasiveness</span><span class="cite-claim-weight">+0.01</span><a href="../claim/477a53071bd6973c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">adipose tissue succinate — increases → advanced stage rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/fd67c830f88881d3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">adipose tissue metabolome panel — distinguishes → rectal cancer vs healthy controls</span><span class="cite-claim-weight">+0.01</span><a href="../claim/4ee98e06e3354a23.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">RHPN2 intronic region (48-nt, rs10411210) — causes → colorectal cancer cell growth</span><span class="cite-claim-weight">+0.60</span><a href="../claim/ca462c01e7191457.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">RHPN2 intronic region knockout — increases → upregulated genes (cell division and metabolic processes)</span><span class="cite-claim-weight">+0.60</span><a href="../claim/1d3e559b15a5c43b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sucrose — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/2022aacfab7d724d.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>90ab8fd78369826b</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:tca cycle metabolites (urinary)">UNKNOWN:tca cycle metabolites (urinary)</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
